These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37563775)

  • 1. Process evaluation of a pharmacist-led intervention aimed at deprescribing and appropriate use of cardiometabolic medication among adult people with type 2 diabetes.
    Baas G; Crutzen S; Smits S; Denig P; Taxis K; Heringa M
    Basic Clin Pharmacol Toxicol; 2024 Jan; 134(1):83-96. PubMed ID: 37563775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist-led intervention aimed at deprescribing and appropriate use of cardiometabolic medication among people with type 2 diabetes.
    Crutzen S; Baas G; Denig P; Heringa M; Taxis K
    Res Social Adm Pharm; 2023 May; 19(5):783-792. PubMed ID: 36740525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers and Enablers of Healthcare Providers to Deprescribe Cardiometabolic Medication in Older Patients: A Focus Group Study.
    Abou J; Crutzen S; Tromp V; Heringa M; Van Marum R; Elders P; Taxis K; Denig P; Hugtenburg J
    Drugs Aging; 2022 Mar; 39(3):209-221. PubMed ID: 35187614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community-based pharmacists' role in deprescribing: A systematic review.
    Bužančić I; Kummer I; Držaić M; Ortner Hadžiabdić M
    Br J Clin Pharmacol; 2022 Feb; 88(2):452-463. PubMed ID: 34155673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of pharmacist-led deprescribing in collaborative primary care settings.
    Trenaman SC; Kennie-Kaulbach N; d'Entremont-MacVicar E; Isenor JE; Goodine C; Jarrett P; Andrew MK
    Int J Clin Pharm; 2022 Oct; 44(5):1216-1221. PubMed ID: 35794285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stakeholder perspectives on pharmacist involvement in a memory clinic to review patients' medication management and assist with deprescribing.
    Cross AJ; Le VJ; George J; Woodward MC; Elliott RA
    Res Social Adm Pharm; 2020 May; 16(5):681-688. PubMed ID: 31405811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-design of a behaviour change intervention to equip geriatricians and pharmacists to proactively deprescribe medicines that are no longer needed or are risky to continue in hospital.
    Scott S; Atkins B; Kellar I; Taylor J; Keevil V; Alldred DP; Murphy K; Patel M; Witham MD; Wright D; Bhattacharya D
    Res Social Adm Pharm; 2023 May; 19(5):707-716. PubMed ID: 36841632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a multicomponent communication training to involve older people in decisions to DEPRESCRIBE cardiometabolic medication in primary care (CO-DEPRESCRIBE): protocol for a cluster randomized controlled trial with embedded process and economic evaluation.
    Stuijt PJC; Heringa M; van Dijk L; Faber A; Burgers JS; Feenstra TL; Taxis K; Denig P
    BMC Prim Care; 2024 Jun; 25(1):210. PubMed ID: 38862899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a hospital deprescribing implementation framework: A focus group study with geriatricians and pharmacists.
    Scott S; Twigg MJ; Clark A; Farrow C; May H; Patel M; Taylor J; Wright DJ; Bhattacharya D
    Age Ageing; 2019 Dec; 49(1):102-110. PubMed ID: 31711097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementation of a compulsory clinical pharmacist-led medication deprescribing intervention in high-risk seniors in the emergency department.
    Jovevski JJ; Smith CR; Roberts JL; Dev S; Iloabuchi TC; Gruber EA; Williams MJ; Slaven JE; Mitchell AM
    Acad Emerg Med; 2023 Apr; 30(4):410-419. PubMed ID: 36794336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are pharmacists' knowledge and practice the key to promoting deprescribing of potentially inappropriate medication: a missing link between treatment and outcomes.
    El-Dahiyat F; Jairoun AA; Al-Hemyari SS; Shahwan M; Hassan N; Jairoun S; Jaber AAS
    Int J Pharm Pract; 2023 Jun; 31(4):387-395. PubMed ID: 37116892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of interprofessional quality circles on deprescribing in Swiss nursing homes: an observational study.
    Mena S; Moullin JC; Schneider M; Niquille A
    BMC Geriatr; 2023 Oct; 23(1):620. PubMed ID: 37789286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Professional roles of general practitioners, community pharmacists and specialist providers in collaborative medication deprescribing - a qualitative study.
    Gerlach N; Michiels-Corsten M; Viniol A; Schleef T; Junius-Walker U; Krause O; Donner-Banzhoff N
    BMC Fam Pract; 2020 Sep; 21(1):183. PubMed ID: 32887551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacist-led telehealth deprescribing for people living with dementia and polypharmacy in primary care: A pilot study.
    Green AR; Quiles R; Daddato AE; Merrey J; Weffald L; Gleason K; Xue QL; Swarthout M; Feeser S; Boyd CM; Wolff JL; Blinka MD; Libby AM; Boxer RS
    J Am Geriatr Soc; 2024 Jul; 72(7):1973-1984. PubMed ID: 38488757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unlocking Deprescribing Potential in Nursing Homes: Insights from a Focus Group Study with Healthcare Professionals.
    Visser AGR; de-Bruijn JBGP; Spaetgens B; Winkens B; Janknegt R; Schols JMGA
    Drugs Aging; 2024 Mar; 41(3):261-270. PubMed ID: 38285238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancing deprescribing: A qualitative understanding of the complexities of pharmacist-led deprescribing in care homes.
    Birt L; Wright DJ; Blacklock J; Bond CM; Hughes CM; Alldred DP; Holland R; Scott S
    Health Soc Care Community; 2022 Nov; 30(6):e6521-e6531. PubMed ID: 36336895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A collaborative intervention for deprescribing: The role of stakeholder and patient engagement.
    Trenaman S; Willison M; Robinson B; Andrew M
    Res Social Adm Pharm; 2020 Apr; 16(4):595-598. PubMed ID: 31350171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation.
    Quek HW; Etherton-Beer C; Page A; McLachlan AJ; Lo SY; Naganathan V; Kearney L; Hilmer SN; Comans T; Mangin D; Lindley RI; Potter K
    Arch Gerontol Geriatr; 2023 Apr; 107():104910. PubMed ID: 36565605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deprescribing potentially inappropriate medications in memory clinic patients (DePIMM): A feasibility study.
    Cross AJ; George J; Woodward MC; Le VJ; Elliott RA
    Res Social Adm Pharm; 2020 Oct; 16(10):1392-1397. PubMed ID: 32014358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers and enablers to deprescribing for older people in care homes: The theory-based perspectives of pharmacist independent prescribers.
    Alharthi M; Wright D; Scott S; Birt L
    Res Social Adm Pharm; 2023 May; 19(5):746-752. PubMed ID: 36732210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.